Faster insulin in pumps may improve after-meal blood sugar in kids with diabetes

NCT ID NCT04149262

Completed Disease control Sponsor: Aristotle University Of Thessaloniki Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a faster-acting insulin (Fiasp) works better than standard rapid insulin (NovoRapid) in insulin pumps for children and teens with type 1 diabetes. Researchers looked at blood sugar levels 30 minutes, 1 hour, and 2 hours after meals using real-world data from 44 participants. The goal was to see if the faster insulin leads to better post-meal glucose control.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: fast-acting insulin aspart (Fiasp)
What this could lead to: If it works, this could show that faster-acting insulin helps control blood sugar better after meals in children with type 1 diabetes using insulin pumps.
What could go wrong: This is a small, completed study with only 44 participants, so results may not apply to all children. It also looks at short-term glucose levels, not long-term outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

type 1 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TYPE 1 DIABETES

Contacts and locations

Locations

Aristotle University of Thessaloniki

Thessaloniki, 54246, Greece

More trials for these conditions

Other studies related to the condition(s) this trial covers.